14 related articles for article (PubMed ID: 38442008)
1. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
2. Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres.
Balsa LM; Ruiz MC; Santa Maria de la Parra L; Baran EJ; León IE
J Inorg Biochem; 2020 Mar; 204():110975. PubMed ID: 31911364
[TBL] [Abstract][Full Text] [Related]
3. Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.
Balsa LM; Solernó LM; Rodriguez MR; Parajón-Costa BS; Gonzalez-Baró AC; Alonso DF; Garona J; León IE
Chem Biol Interact; 2023 Oct; 384():110685. PubMed ID: 37666443
[TBL] [Abstract][Full Text] [Related]
4. New copper(II) and oxidovanadium(IV) complexes with a vitamin B
Balsa LM; Ferretti V; Sottile M; Nunes P; Costa Pessoa J; Correia I; León IE
Dalton Trans; 2024 Feb; 53(7):3039-3051. PubMed ID: 38111362
[TBL] [Abstract][Full Text] [Related]
5. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
6. Promising Dual Anticancer and Antimetastatic Action by a Cu(II) Complex Derived from Acylhydrazone on Human Osteosarcoma Models.
Santa Maria de la Parra L; Romo AIB; Rodríguez-López J; Nascimento OR; Echeverría GA; Piro OE; León IE
Inorg Chem; 2024 Mar; 63(11):4925-4938. PubMed ID: 38442008
[TBL] [Abstract][Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
